Reconstruction of a generic metabolic network model of cancer cells

Mahdieh Hadi1, Sayed-Amir Marashi

  • 1Department of Biotechnology, College of Science, University of Tehran, Tehran, Iran. Marashi@ut.ac.ir.

Molecular Biosystems
|September 9, 2014
PubMed

Insights

Researchers developed a metabolic network model to identify essential cancer genes and reactions for drug discovery. This model accurately predicts cancer cell metabolism and outperforms previous models in simulated body fluid conditions.

Area of Science:

  • Computational biology
  • Systems biology
  • Cancer research

Background:

  • Metabolic network models are crucial for identifying cancer drug targets.
  • Understanding cancer cell metabolism is key to developing targeted therapies.

Purpose of the Study:

  • To present a generic constraint-based model of cancer metabolism.
  • To predict metabolic phenotypes and essential genes/reactions in cancer cells.
  • To investigate the link between oncogene activation and tumor suppressor gene inactivation.

Main Methods:

  • Reconstruction of a constraint-based metabolic network model.
  • Utilizing data on tumor suppressor genes.
  • Simulating cancer cell metabolism in a medium mimicking body fluids.

Main Results:

  • The model successfully predicts cancer cell metabolic phenotypes.
  • Inactivation of tumor suppressor genes explains oncogene-related reactions.
  • The proposed model shows superior performance compared to previous models in predicting gene expression.

Conclusions:

  • Constraint-based metabolic models are effective tools for cancer drug discovery.
  • The model provides insights into the regulatory mechanisms of cancer metabolism.
  • This approach enhances the prediction of cancer cell behavior and potential therapeutic targets.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Protein Networks02:26

Protein Networks

An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K